1. Home
  2. ATAI
  3. ATAI News

Latest ATAI Life Sciences N.V. (ATAI) News on July 3, 2025

Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?
ATAI

Zacks

8 days ago

Are Medical Stocks Lagging atai Life Sciences (ATAI) This Year?

Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target
ATAI

Insider Monkey

8 days ago

Maxim Group Maintains a Buy on Atai Life Sciences (ATAI) With a $6 Price Target

Trump Trade: President said to weigh possible U.S. strike against Iran
ATAI

TipRanks

14 days ago

Trump Trade: President said to weigh possible U.S. strike against Iran

Psychedelic advocates hopeful Trump administration will support space, STAT says
ATAI

TipRanks

14 days ago

Psychedelic advocates hopeful Trump administration will support space, STAT says

This Illegal Psychedelic Is Hailed as a ‘Revolutionary Breakthrough’
ATAI

WSJ

14 days ago

This Illegal Psychedelic Is Hailed as a ‘Revolutionary Breakthrough’

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
ATAI

GlobeNewswire

a month ago

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies

atai Life Sciences to Participate in Upcoming Investor Conferences
ATAI

GlobeNewswire

a month ago

atai Life Sciences to Participate in Upcoming Investor Conferences

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies
ATAI

TipRanks

a month ago

Phase 2a data for BPL-003 ‘encouraging’ for Atai Life Sciences, says Jefferies

Home Depot backs outlook as U.S. sales ticked up: Morning Buzz
ATAI

TipRanks

a month ago

Home Depot backs outlook as U.S. sales ticked up: Morning Buzz

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression
ATAI

GlobeNewswire

a month ago

atai Life Sciences Announces Positive Topline Data from Part 2 of Beckley Psytech’s Phase 2a Study of BPL-003 in Combination with SSRIs for Treatment-Resistant Depression

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates
ATAI

GlobeNewswire

2 months ago

atai Life Sciences Reports First Quarter 2025 Financial Results and Recent Corporate Updates

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder
ATAI

GlobeNewswire

2 months ago

atai Life Sciences Announces First Patient Dosed in Phase 2 Study of EMP-01 for the Treatment of Social Anxiety Disorder

Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
ATAI

TipRanks

3 months ago

Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial

Psychedelic: Exclusive talk with biotech company Clearmind Medicine
ATAI

TipRanks

3 months ago

Psychedelic: Exclusive talk with biotech company Clearmind Medicine

Psychedelic: atai Life Sciences, NRx report quarterly results
ATAI

TipRanks

3 months ago

Psychedelic: atai Life Sciences, NRx report quarterly results

Atai Life Sciences Full Year 2024 Earnings: Misses Expectations
ATAI

Simply Wall St.

3 months ago

Atai Life Sciences Full Year 2024 Earnings: Misses Expectations

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
ATAI

GlobeNewswire

4 months ago

atai Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial
ATAI

TipRanks

4 months ago

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression
ATAI

GlobeNewswire

4 months ago

atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression

atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression
ATAI

GlobeNewswire

4 months ago

atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression

Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025
ATAI

Insider Monkey

4 months ago

Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025

Psychedelic: GH Research, Compass Pathways report earnings results
ATAI

TipRanks

4 months ago

Psychedelic: GH Research, Compass Pathways report earnings results

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference
ATAI

GlobeNewswire

4 months ago

atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
ATAI

GlobeNewswire

4 months ago

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

atai Life Sciences Announces Pricing of Public Offering of Common Shares
ATAI

GlobeNewswire

5 months ago

atai Life Sciences Announces Pricing of Public Offering of Common Shares

atai Life Sciences Announces Proposed Public Offering of Common Shares
ATAI

GlobeNewswire

5 months ago

atai Life Sciences Announces Proposed Public Offering of Common Shares

ATAI

Market Exclusive

5 months ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Atai Life Sciences And 2 Other Promising Penny Stocks On US Exchanges
ATAI

Simply Wall St.

5 months ago

Atai Life Sciences And 2 Other Promising Penny Stocks On US Exchanges

atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder
ATAI

GlobeNewswire

5 months ago

atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder

ATAI

Market Exclusive

6 months ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health
ATAI

GlobeNewswire

6 months ago

atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health

US Penny Stocks To Consider In December 2024
ATAI

Simply Wall St.

6 months ago

US Penny Stocks To Consider In December 2024

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch
ATAI

Simply Wall St.

7 months ago

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch

atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
ATAI

GlobeNewswire

8 months ago

atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
ATAI

GlobeNewswire

8 months ago

Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer

374Water And 2 Other Promising US Penny Stocks To Watch
ATAI

Simply Wall St.

8 months ago

374Water And 2 Other Promising US Penny Stocks To Watch

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
ATAI

GlobeNewswire

9 months ago

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
ATAI

GlobeNewswire

10 months ago

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
ATAI

GlobeNewswire

a year ago

atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
ATAI

GlobeNewswire

a year ago

atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference
ATAI

GlobeNewswire

a year ago

atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference

atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
ATAI

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller
ATAI

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up
ATAI

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Trump loyalists proud to support 'felon' at Las Vegas rally
ATAI

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
ATAI

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

The Best Woody Perfume For Women
ATAI

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
ATAI

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

ATAI

Insider Monkey

a year ago

Best Date Night Fragrance in 2024

Lotto 6/49 - $64 million up for grabs in the next draw!
ATAI

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
ATAI

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
ATAI

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
ATAI

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
ATAI

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
ATAI

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
ATAI

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
ATAI

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
ATAI

GlobeNewswire

a year ago

atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
ATAI

GlobeNewswire

a year ago

atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
ATAI

GlobeNewswire

a year ago

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
ATAI

Simply Wall St.

a year ago

Atai Life Sciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
ATAI

GlobeNewswire

a year ago

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression

atai Life Sciences advances VLS-01 for treatment-resistant depression
ATAI

News Direct

a year ago

atai Life Sciences advances VLS-01 for treatment-resistant depression

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
ATAI

GlobeNewswire

a year ago

atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
ATAI

GlobeNewswire

a year ago

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

J.P. Morgan & Fidelity Reports: Realistic Retirement Rate of Return By Asset Class
ATAI

SmartAsset

a year ago

J.P. Morgan & Fidelity Reports: Realistic Retirement Rate of Return By Asset Class

ATAI

Associated Press Finance

a year ago

CNB: Q4 Earnings Snapshot

CNB Financial Corporation Reports Fourth Quarter and Full-Year 2023 Results
ATAI

GlobeNewswire

a year ago

CNB Financial Corporation Reports Fourth Quarter and Full-Year 2023 Results

Gear Up for Washington Trust (WASH) Q4 Earnings: Wall Street Estimates for Key Metrics
ATAI

Zacks

a year ago

Gear Up for Washington Trust (WASH) Q4 Earnings: Wall Street Estimates for Key Metrics

Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long
ATAI

Simply Wall St.

a year ago

Analysts Expect Breakeven For Theravance Biopharma, Inc. (NASDAQ:TBPH) Before Long

The Manitowoc Company, Inc. (MTW) Increases Yet Falls Behind Market: What Investors Need to Know
ATAI

Zacks

a year ago

The Manitowoc Company, Inc. (MTW) Increases Yet Falls Behind Market: What Investors Need to Know

ATAI

Business Wire

a year ago

Manitowoc Board of Directors Elects Ryan M. Gwillim as New Director

Voya Equity Closed End Fund Declares Distribution
ATAI

Business Wire

a year ago

Voya Equity Closed End Fund Declares Distribution

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains
ATAI

Simply Wall St.

a year ago

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains

The Manitowoc Company, Inc. (MTW) Stock Dips While Market Gains: Key Facts
ATAI

Zacks

a year ago

The Manitowoc Company, Inc. (MTW) Stock Dips While Market Gains: Key Facts

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment
ATAI

StockStory

a year ago

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment

Polestar announces Board and Management appointments
ATAI

Business Wire

a year ago

Polestar announces Board and Management appointments

Net Lease Office Properties Announces Sales of Four U.S. Office Properties Totaling $43 Million
ATAI

PR Newswire

a year ago

Net Lease Office Properties Announces Sales of Four U.S. Office Properties Totaling $43 Million

An Intrinsic Calculation For Torrid Holdings Inc. (NYSE:CURV) Suggests It's 37% Undervalued
ATAI

Simply Wall St.

a year ago

An Intrinsic Calculation For Torrid Holdings Inc. (NYSE:CURV) Suggests It's 37% Undervalued

Denny's (DENN) Reaches Test Agreement With Franklin Junction
ATAI

Zacks

a year ago

Denny's (DENN) Reaches Test Agreement With Franklin Junction

Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ATAI

GlobeNewswire

a year ago

Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

American Woodmark (AMWD) Rises But Trails Market: What Investors Should Know
ATAI

Zacks

a year ago

American Woodmark (AMWD) Rises But Trails Market: What Investors Should Know

SiTime to Present at the Needham Growth Conference on January 16, 2024
ATAI

GlobeNewswire

a year ago

SiTime to Present at the Needham Growth Conference on January 16, 2024

ATAI

Market Exclusive

a year ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Ecstasy-for-Medicine Advocate Raises $100 Million
ATAI

The Wall Street Journal

a year ago

Ecstasy-for-Medicine Advocate Raises $100 Million

atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics
ATAI

GlobeNewswire

a year ago

atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army
ATAI

Business Wire

a year ago

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army

atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
ATAI

GlobeNewswire

2 years ago

atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)

Should You Be Worried About Daseke, Inc.'s (NASDAQ:DSKE) 9.1% Return On Equity?
ATAI

Simply Wall St.

2 years ago

Should You Be Worried About Daseke, Inc.'s (NASDAQ:DSKE) 9.1% Return On Equity?

Shore Bancshares Third Quarter 2023 Earnings: Misses Expectations
ATAI

Simply Wall St.

2 years ago

Shore Bancshares Third Quarter 2023 Earnings: Misses Expectations

TFI International Inc. (TFII) Surges 8.1%: Is This an Indication of Further Gains?
ATAI

Zacks

2 years ago

TFI International Inc. (TFII) Surges 8.1%: Is This an Indication of Further Gains?

Limoneira to Present at the 26th Annual ICR Conference
ATAI

Business Wire

2 years ago

Limoneira to Present at the 26th Annual ICR Conference

Materialise (NASDAQ:MTLS) Will Want To Turn Around Its Return Trends
ATAI

Simply Wall St.

2 years ago

Materialise (NASDAQ:MTLS) Will Want To Turn Around Its Return Trends

HarborOne Bancorp, Inc. Declares Fourth Quarter 2023 Cash Dividend
ATAI

Business Wire

2 years ago

HarborOne Bancorp, Inc. Declares Fourth Quarter 2023 Cash Dividend

Share on Social Networks: